247 related articles for article (PubMed ID: 15037557)
1. Adverse prognostic significance of new diabetes in treated hypertensive subjects.
Verdecchia P; Reboldi G; Angeli F; Borgioni C; Gattobigio R; Filippucci L; Norgiolini S; Bracco C; Porcellati C
Hypertension; 2004 May; 43(5):963-9. PubMed ID: 15037557
[TBL] [Abstract][Full Text] [Related]
2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
[TBL] [Abstract][Full Text] [Related]
3. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects.
Verdecchia P; Reboldi G; Porcellati C; Schillaci G; Pede S; Bentivoglio M; Angeli F; Norgiolini S; Ambrosio G
J Am Coll Cardiol; 2002 Mar; 39(5):878-85. PubMed ID: 11869856
[TBL] [Abstract][Full Text] [Related]
4. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.
Verdecchia P; Angeli F; Gattobigio R; Sardone M; Pede S; Reboldi GP
Am J Hypertens; 2006 May; 19(5):493-9. PubMed ID: 16647622
[TBL] [Abstract][Full Text] [Related]
5. Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects.
Eguchi K; Ishikawa J; Hoshide S; Ishikawa S; Pickering TG; Schwartz JE; Homma S; Shimada K; Kario K
Am Heart J; 2007 Jul; 154(1):79.e9-15. PubMed ID: 17584557
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.
Clement DL; De Buyzere ML; De Bacquer DA; de Leeuw PW; Duprez DA; Fagard RH; Gheeraert PJ; Missault LH; Braun JJ; Six RO; Van Der Niepen P; O'Brien E;
N Engl J Med; 2003 Jun; 348(24):2407-15. PubMed ID: 12802026
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value.
Verdecchia P; Angeli F; Gattobigio R; Sardone M; Porcellati C
Hypertension; 2005 Mar; 45(3):412-8. PubMed ID: 15655115
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure variability and cardiovascular risk in treated hypertensive patients.
Pierdomenico SD; Lapenna D; Di Tommaso R; Di Carlo S; Esposito AL; Di Mascio R; Ballone E; Cuccurullo F; Mezzetti A
Am J Hypertens; 2006 Oct; 19(10):991-7. PubMed ID: 17027816
[TBL] [Abstract][Full Text] [Related]
10. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
11. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
13. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
14. New-onset diabetes in treated hypertensive patients.
Verdecchia P; Angeli F; Reboldi GP; Gattobigio R
Curr Hypertens Rep; 2005 Jun; 7(3):174-9. PubMed ID: 15913490
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors are not treated to target in hypertensive patients in primary care.
Nieburg I; Kahan T
Blood Press; 2010 Jun; 19(3):176-81. PubMed ID: 20429693
[TBL] [Abstract][Full Text] [Related]
16. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
Pierdomenico SD; Lapenna D; Cuccurullo F
Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive treatment in the type 2 diabetic].
Fournier A
Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
[No Abstract] [Full Text] [Related]
18. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
19. Is the development of diabetes with antihypertensive therapy a problem?--Pro.
Verdecchia P; Angeli F; Reboldi G; Gattobigio R
J Clin Hypertens (Greenwich); 2006 Feb; 8(2):120-6. PubMed ID: 16470081
[TBL] [Abstract][Full Text] [Related]
20. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
